{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-112038","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2024-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.714687+00:00","generated_at":"2026-05-30T21:27:29.197562+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sight Sciences: Final Medicare LCDs confirm coverage for OMNI and SION procedures but impose usage limitations","bullets":["Four MACs (Palmetto GBA, CGS, NGS, WPS) published final LCDs effective Nov 17, 2024, confirming coverage for single MIGS with phaco.","Coverage continues for canaloplasty/trabeculotomy (OMNI) and goniotomy (SION) procedures.","Limitations: non-coverage for first-line mild-to-moderate glaucoma, combined MIGS with aqueous shunt, and phaco with multiple MIGS.","Sight Sciences plans to engage with MACs, CMS, and clinical societies on coverage issues."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-112038","json":"https://secwatch.observer/filing/0000950170-24-112038.json","markdown":"https://secwatch.observer/filing/0000950170-24-112038.md","text":"https://secwatch.observer/filing/0000950170-24-112038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024112038/0000950170-24-112038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024112038/sght-20241003.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T21:27:29.197562+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}